Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival

Journal of the National Cancer Institute

Volumn 105, Issue 4, 2013, Pages 302-309

  Gamazon, Eric R ^a   Pinto, Navin ^a   Konkashbaev, Anuar ^a   Im, Hae Kyung ^a   Diskin, Sharon J ^b   London, Wendy B ^c,d   Maris, John M ^b   Dolan, M Eileen ^a   Cox, Nancy J ^a   Cohn, Susan L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c HARVARD UNIVERSITY   (United States)

^d CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SPERM ANTIGEN;

ALLELE; ARTICLE; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; EUROPEAN AMERICAN; EVENT FREE SURVIVAL; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; NEGRO; NEUROBLASTOMA; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN AMERICANS; CHILD, PRESCHOOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFANT; KAPLAN-MEIER ESTIMATE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; UNITED STATES;

EID: 84875027471     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djs503     Document Type: Article

References (34)

1. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet. 2007;369(9579): 2106-2120.
2. Ademuyiwa FO, Edge SB, Erwin DO, et al. Breast cancer racial disparities: unanswered questions. Cancer Res. 2011;71(3): 640-644.
3. Allard JE, Maxwell GL. Race disparities between black and white women in the incidence, treatment, and prognosis of endometrial cancer. Cancer Control. 2009;16(1): 53-56.
4. Downs LS, Smith JS, Scarinci I, et al. The disparity of cervical cancer in diverse populations. Gynecol Oncol. 2008;109(2 Suppl):S22-S30.
5. Goggins WB, Lo FF. Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: evidence from the SEER database 1988-2008. Cancer Causes Control. 2012;23(5): 737-743.
6. Henderson TO, Bhatia S, Pinto N, et al. Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study. J Clin Oncol. 2011;29(1): 76-82.
7. Maris JM, Mosse YP, Bradfield JP, et al. Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med. 2008;358(24): 2585-2593.
8. Wang K, Diskin SJ, Zhang H, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011;469(7329): 216-220.
9. Capasso M, Devoto M, Hou C, et al. Common variations in BARD1 influence susceptibility to high-risk neuroblastoma. Nat Genet. 2009;41(6): 718-723.
10. Diskin SJ, Hou C, Glessner JT, et al. Copy number variation at 1q21.1 associated with neuroblastoma. Nature. 2009;459(7249): 987-991.
11. Nguyen le B, Diskin SJ, Capasso M, et al. Phenotype restricted genomewide association study using a gene-centric approach identifies three lowrisk neuroblastoma susceptibility Loci. PLoS Genet. 2011;7(3):e1002026.
12. Latorre V, Diskin SJ, Diamond MA, et al. Replication of neuroblastoma SNP association at the BARD1 Locus in African-Americans. Cancer Epidemiol Biomarkers Prev. 2012;21(4): 658-663.
13. Pluzhnikov A, Below JE, Konkashbaev A, et al. Spoiling the whole bunch: quality control aimed at preserving the integrity of high-throughput genotyping. Am J Hum Genet. 2010;87(1): 123-128.
14. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426(6968): 789-796.
15. Price AL, Patterson NJ, Plenge RM, et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8): 904-909.
16. Ding C, He X. K-means clustering via principal component analysis. In: 21st Internaltional Conference on Machine Learning; July 4-8, 2004; Banff, Canada.
17. Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res. 2009;19(9): 1655-1664.
18. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3): 515-526.
19. Teo YY, Small KS, Kwiatkowski DP. Methodological challenges of genomewide association analysis in Africa. Nat Rev Genet. 2010;11(2): 149-160.
20. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A. 2003;100(16): 9440-9445.
21. Coop G, Pickrell JK, Novembre J, et al. The role of geography in human adaptation. PLoS Genet. 2009;5(6):e1000500.
22. Pickrell JK, Coop G, Novembre J, et al. Signals of recent positive selection in a worldwide sample of human populations. Genome Res. 2009;19(5): 826-837.
23. Pritchard JK, Pickrell JK, Coop G. The genetics of human adaptation: hard sweeps, soft sweeps, and polygenic adaptation. Curr Biol. 2010;20(4):R208-R215.
24. Cann HM, de Toma C, Cazes L, et al. A human genome diversity cell line panel. Science. 2002;296(5566): 261-262.
25. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319): 1061-1073.
26. Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature. 2011;473(7345): 43-49.
27. Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(database issue):D930-D934.
28. Wheeler HE, Gorsic LK, Welsh M, et al. Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans. PLoS One. 2011;6(7):e21920.
29. Price AL, Tandon A, Patterson N, et al. Sensitive detection of chromosomal segments of distinct ancestry in admixed populations. PLoS Genet. 2009;5(6):e1000519.
30. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academies Press; 2003.
31. Tanaka M, Kigasawa H, Kato K, et al. A prospective study of a long-term follow-up of an observation program for neuroblastoma detected by mass screening. Pediatr Blood Cancer. 2010;54(4): 573-578.
32. Berthold F, Hero B, Breu H, et al. The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients. Ann Oncol. 1996;7(2): 183-187.
33. Brodeur GM, Hayes FA, Green AA, et al. Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res. 1987;47(16): 4248-4253.
34. Auer J, Senechal H, De Almeida M. Sperm-associated and circulating IgA and IgG classes of antibodies recognise different antigens on the human sperm plasma membrane. J Reprod Immunol. 1997;34(2): 121-136.